
World’s leading provider of genomic-based diagnostic tests that help optimize cancer care through @OncotypeIQ
Redwood City, CA
Joined September 2009
- Tweets2.8K
- Following266
- Followers3.1K
- Likes482
Genomic Health® retweeted
A respected physician and researcher, Joseph Sparano, MD, with @EinsteinMed, led the practice‐changing TAILORx clinical trial for #breastcancer treatment and is working to close #disparities in cancer care. ow.ly/ubPO30pU8FF
Genomic Health® retweeted
ICYMI: We expanded our cancer diagnostics capabilities through our integration with @GenomicHealth. More here: exas.co/357JZxU
Genomic Health® retweeted
.@ExactSciences + @GenomicHealth complete their merger, creating a leading global #cancer diagnostics company ow.ly/hcML30pSgdB
Genomic Health® retweeted
Kicking off November w/ annual @bayareacancer conference. Glad to hear @l_schapira of @StanfordMed differentiate btwn side effects & long term health consequences of cancer treatment. Regardless of stage, cancer is not ever "won and done." #bcsm #bccww #CancerResearch
Genomic Health® retweeted
Every #breastcancer patient deserves personalized treatment #NoMatterMyAge. Learn more about your options at NoMatterMyAge.org
Genomic Health® retweeted
Attending @MAoftheAUA meeting next week? Meet the @GenomicHealth team in the exhibit hall to learn more about #Oncotype DX Genomic Prostate Score® assay. https://nitter.cf/t.co/iGgoVHNGI7 #MAAUA #prostatecancer
Genomic Health® retweeted
@CCRTIreland @ProfJohnCrown want to thank our gold sponsors @Pfizer_Ireland @EisaiUS @bmsnews @GenomicHealth @Boehringer for sponsoring #TransOncXII @HerbertPark Your support is greatly appreciated as always. #cancerresearch @nicb_dcu @DcuBiotech @DCUFSH
Genomic Health® retweeted
New findings support the use of the 21-gene RS assay to guide the use of adjuvant chemotherapy in patients with hormone receptor–positive, ERBB2-negative, axillary node-negative #breastcancer ja.ma/2lIAeoR #ESMO19
Genomic Health® retweeted
Latest results from TAILORx, the largest ever #breastcancer treatment trial. Bob Gray, PhD, is lead statistician for TAILORx, which continues to define new standards in early breast cancer. @eaonc #ESMO19
New findings support the use of the 21-gene RS assay to guide the use of adjuvant chemotherapy in patients with hormone receptor–positive, ERBB2-negative, axillary node-negative #breastcancer ja.ma/2lIAeoR #ESMO19
Genomic Health® retweeted
Toll, dass der G-BA-Beschluss zu @OncotypeIQ schnell in Kraft getreten ist und Frauen mit #Brustkrebs den Test nun von der GKV gezahlt bekommen. Warum wir uns so stark für den #Oncotype eingesetzt haben, dazu nochmal unser Interview mit @chbernards: sbk.org/unsere-themen/versor…
Genomic Health® retweeted
#cap19ORL - Learn how the #Oncotype IQ Genomic Intelligence Platform provides actionable #genomic intelligence to inform #cancertreatment decisions across your patient journey at @GenomicHealth's booth https://nitter.cf/t.co/5rG1sq6mZQ
Genomic Health® retweeted
We have a winner! Here's our new 2019 Grow & Give T-Shirt!
When you raise $250 through ZERO's Grow & Give (G&G) Campaign, you'll receive one of these awesome t-shirts! Sign up now to join the G&G movement: https://nitter.cf/t.co/9REsJnZJBH #EndProstateCancer #prostatecancer #GrowandGive
Genomic Health® retweeted
Zero cancer day!!!
pscp.tv/w/cFoT_TFxTFFHSm1tR3…
Genomic Health® retweeted
Attending #cap10ORL next week and have questions about the @GenomicHealth DX suite? Swing by booth 411 to explore the science and talk to our team https://nitter.cf/t.co/9PYhjmzLBs cc: @Pathologists #urology #onocolgy
Genomic Health® retweeted
#BreastHealth launches today at ow.ly/P3gl50w2tt7 and distributed in the
@guardian
- featuring Dr Sophie McGrath from
@GenomicHealth
speak about how genomic testing is helping women tailor their breast cancer care.
Genomic Health® retweeted
Not all young women have more aggressive forms of #breastcancer. Getting as much information as you can about your cancer, including a genomic test result, may help you better understand the treatment option best for you. #NoMatterMyAge NoMatterMyAge.org
Genomic Health® retweeted
TAILORx established the role of the 21-gene predictor of genetic risk in ascertaining treatment for women with hormone-receptor–positive, human epidermal growth factor receptor 2–negative #breastcancer. Learn more: nej.md/2Z1njMX #ASCO19
Genomic Health® retweeted
How does the #Oncotype DX Breast Recurrence Score® test compare to other #genomic tests? Stop by @GenomicHealth's #ASCO19 booth 12097 to find out https://nitter.cf/t.co/q8AvtY1v81 #chemo
Genomic Health® retweeted
Thanks for visiting our #AUA19 exhibit and @GenomicHealth team to learn how the #Oncotype DX AR-V7 Nucleus Detect™ assay can help your metastatic castrate resistant #prostatecancer patients determine if they will respond to AR-targeted therapies https://nitter.cf/t.co/1OuoZ0BeEc
































